BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12614245)

  • 21. Screening by lower urinary tract symptoms vs asymptomatic prostate-specific antigen levels leading to radical prostatectomy in Danish men: tumour characteristics and treatment outcome.
    Borre M
    BJU Int; 2009 Jul; 104(2):205-8. PubMed ID: 19154477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
    Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The changes of prostate specific antigen (PSA) after treatment with alpha 1-adrenergic receptor antagonists in men with 4.0-9.9 ng/ml PSA level--a study for comparison of benign prostatic hyperplasia/lower urinary tract symptom (BPH/LUTS) and prostate cancer].
    Hanai T; Matsumoto S; Shouji S; Usui Y; Tang XY; Kato Y; Iguchi M; Uemura H; Terachi T
    Hinyokika Kiyo; 2009 Apr; 55(4):187-91. PubMed ID: 19462822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
    Walz J; Suardi N; Hutterer GC; Perrotte P; Gallina A; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    J Endourol; 2008 Feb; 22(2):369-76. PubMed ID: 18294044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of prostate cancer among men aged 40+ living in Osman Gazi health care district.
    Çeber E; Şimşir A; Umar DÇ; Karababa AO; Günaydın G; Çal Ç; Özentürk G
    Asian Pac J Cancer Prev; 2010; 11(2):473-8. PubMed ID: 20843136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
    Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
    BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
    Bulbul MA; Wazzan W; Hijaz A; Shaar A
    J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey.
    Wang Y; Hu H; Xu K; Wang X; Na Y; Kang X
    Int Urogynecol J; 2015 Jun; 26(6):911-9. PubMed ID: 25653032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy.
    Singh R; Cahill D; Popert R; O'Brien TS
    BJU Int; 2003 Dec; 92(9):932-5. PubMed ID: 14632850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.
    Kane RA; Littrup PJ; Babaian R; Drago JR; Lee F; Chesley A; Murphy GP; Mettlin C
    Cancer; 1992 Mar; 69(5):1201-7. PubMed ID: 1371234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
    Bretton PR
    South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of lower urinary tract symptoms with sexual dysfunction: a cross-cultural study between Japanese and American men with localized prostate cancer.
    Namiki S; Litwin MS; Kwan L; Kagawa-Singer M; Ishidoya S; Saito S; Arai Y
    BJU Int; 2009 Oct; 104(8):1071-6. PubMed ID: 19519765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Summary of the NHG practice guideline 'Lower urinary tract symptoms in men'].
    Blanker MH; Klomp MA; van den Donk M; van der Heide WK; Opstelten W; Burgers JS
    Ned Tijdschr Geneeskd; 2013; 157(18):A6178. PubMed ID: 23635505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening.
    Reggio E; de Bessa J; Junqueira RG; Timm O; Sette MJ; Sansana V; Gomes CM
    Int J Impot Res; 2007; 19(5):492-5. PubMed ID: 17554395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of abdominal ultrasound, urine cytology and prostate-specific antigen testing in the lower urinary tract symptoms clinic.
    Patel NS; Blick C; Kumar PV; Malone PR
    Int J Clin Pract; 2009 Dec; 63(12):1734-8. PubMed ID: 19930334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
    Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
    Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological benefits of prostate cancer screening: the role of reassurance.
    Cantor SB; Volk RJ; Cass AR; Gilani J; Spann SJ
    Health Expect; 2002 Jun; 5(2):104-13. PubMed ID: 12031051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.